Skip to Content

LL501 (Phenobarbital 15 mg)

Pill imprint LL501 has been identified as Phenobarbital 15 mg.

Phenobarbital is used in the treatment of seizures; sedation; insomnia; hyperbilirubinemia and belongs to the drug classes barbiturate anticonvulsants, barbiturates. There is positive evidence of human fetal risk during pregnancy. Phenobarbital 15 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Phenobarbital
Imprint:
LL501
Strength:
15 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Barbiturate anticonvulsants
Barbiturates
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
4 - Some potential for abuse
Manufacturer:
Larken Laboratories, Inc.

View Details Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide